Newly Discovered genetic Form of Diabetes Impacts Infants and Neurological Development

A groundbreaking​ international‍ study has identified a previously unknown form of diabetes affecting babies, offering critical insights into⁤ the early failures of‍ insulin production. ‍Researchers have pinpointed mutations ‌in the TMEM167A gene as the root cause of this rare condition, ⁤which uniquely presents alongside neurological challenges ​like epilepsy and microcephaly. ​This finding ‍not only sheds light on a⁢ devastating​ illness but also opens new avenues for understanding and perhaps treating more common forms of⁣ diabetes.

Unraveling the Genetic Basis of Neonatal ​Diabetes

While diabetes ​in infants – defined as onset within the first six ⁣months⁣ of life – is rare, ⁤it’s ‌often linked to genetic factors. in over ⁤85% of cases, inherited DNA changes are the culprit [[1]]. This new research‍ focused on a ‌small cohort of ​six children who exhibited not⁢ only diabetes but‍ also significant ‍neurological ⁤symptoms. ⁣The common thread? Mutations‍ within the ⁤ TMEM167A ⁣ gene.

The Role of⁢ TMEM167A: ⁤A Critical Gene for Multiple Systems

The ‌ TMEM167A gene, previously not well understood,‍ appears to ‍be ⁤essential for⁢ the proper functioning ‌of both insulin-producing beta ⁣cells and neurons⁤ [[1]]. Interestingly, it‍ seems to be largely dispensable for other cell‌ types, ⁢suggesting a highly specific and ​crucial role in these two critical systems. This dual importance explains why affected infants experience ⁣both metabolic and neurological dysfunction.

Stem Cell Research ⁢Illuminates the Disease Mechanism

To understand how ⁤mutations in TMEM167A ⁤led to​ disease, researchers⁢ employed⁢ cutting-edge stem cell technology. Professor Miriam ​Cnop’s ‌team at Université ‌Libre de Bruxelles (ULB) transformed stem cells into pancreatic beta cells​ – the very ‍cells responsible for insulin production. They then utilized CRISPR gene-editing techniques to deliberately alter the TMEM167A gene, mimicking the mutations found in‌ the ⁢affected children.

The results ⁢were telling. damaging the TMEM167A gene impaired the ability of ⁢beta cells to function correctly. ‍ The⁤ cells ‌experienced ‌increased internal stress, triggering a cascade of events ⁤that ultimately ‌led to cell‍ death. This​ provides a clear mechanistic link between the genetic mutation and the development of diabetes.

Implications for Understanding and Treating Diabetes

Dr. Elisa de Franco of the​ University of Exeter emphasizes the importance of this finding: ⁤“Finding the‌ DNA changes that cause diabetes‌ in babies gives us⁢ a unique way‍ to find​ the genes that play key roles in making ​and secreting ⁣insulin.” [[1]] The‌ research ⁤clarifies the function of TMEM167A and its⁣ critical role in​ insulin secretion.

professor cnop highlights the broader potential of this research: “The ability⁤ to⁤ generate insulin-producing cells from stem cells has enabled us to study what is ⁤dysfunctional in the beta cells of patients⁤ with⁢ rare forms and ⁣also other types‍ of diabetes. This is an remarkable model⁣ for studying disease mechanisms and ⁢testing treatments.” [[1]]

beyond Neonatal Diabetes: ‍A ‍Potential ‌Impact ⁢on Common Forms

While this discovery centers on a rare genetic‍ condition, its implications extend‍ far beyond. With nearly 589 million⁢ people worldwide affected by diabetes [[1]], ⁢understanding‌ the fundamental mechanisms of insulin production and beta cell function is crucial. The insights gained from studying​ TMEM167A could inform‌ research⁤ into more prevalent types of⁢ diabetes, potentially ⁤leading to⁣ new therapeutic strategies.

Research Details​ and ‍Funding

This collaborative research effort involved the University of Exeter ⁣Medical School, université ‍Libre de Bruxelles (ULB), and ⁢several other international‍ partners. The study, titled ‘Recessive TMEM167A variants cause neonatal diabetes, microcephaly and ‌epilepsy syndrome’, was ‌published⁢ in The journal of​ Clinical ⁢Inquiry [[2]] and [[3]]. Funding was provided by Diabetes UK, the European Foundation for the study of ⁣Diabetes, Novo Nordisk foundation, the ULB Foundation, the FNRS, the FRFS-WELBIO, the Research Foundation Flanders (FWO), and the Excellence of ⁣Science‍ (EOS) program. Dr. De Franco received support from the NIHR Exeter Biomedical research ⁤Center.

Key Takeaways:

• Mutations in the ‌ TMEM167A gene‌ cause a rare form of neonatal diabetes accompanied by neurological issues.
• TMEM167A is ​vital for ⁤the function of both insulin-producing beta cells⁣ and⁢ neurons.
• Stem cell research has revealed ⁤that damaging⁤ TMEM167A ⁤leads to beta⁢ cell dysfunction and death.
• This discovery could provide valuable insights into the mechanisms of all types of diabetes.